<?xml version="1.0" encoding="UTF-8"?>
<p>Researchers have put forth their best efforts in developing effective treatments and vaccine candidates, and have succeeded to a significant extent in identifying several repurposed drugs, monoclonal therapeutic antibodies, and vaccine candidates. However, many such treatment options are in the different stages of pre-clinical and clinical development. To date, no approved, specific antiviral agent or vaccine against SARS-CoV-2 is available for human use. The development of next-generation effective diagnostics has undergone a great leap. This review highlights the significant progress made in the measures for the resolution of the COVID-19 pandemic, using virus genomic analysis, the assessment of global epidemiological trends, transmission patterns, the present-day status of therapeutics, and public health preparedness plans for controlling the wider dissemination of the disease.</p>
